Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. It is used for cancers such as breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma, as well as autoimmune diseases such as psoriasis…
History & Applications
Explore the main themes, entities and connections around Methotrexate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used effects cancer treatment arthritis acid rheumatoid doses may drug use side folic disease lower autoimmune also toxicity risk treat
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Methotrexate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Methotrexate | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Methotrexate | ATC code | L01BA01 (WHO) L04AX03 (WHO) | 1.00 | infobox |
| Methotrexate | Bioavailability | 60% at lower doses, less at higher doses. | 1.00 | infobox |
| Methotrexate | CAS Number | 59-05-2 Y | 1.00 | infobox |
| Methotrexate | ChEBI | CHEBI:44185 Y | 1.00 | infobox |
| Methotrexate | ChEMBL | ChEMBL34259 Y | 1.00 | infobox |
| Methotrexate | ChemSpider | 112728 Y | 1.00 | infobox |
| Methotrexate | CompTox Dashboard (EPA) | DTXSID4020822 | 1.00 | infobox |
| Methotrexate | DrugBank | DB00563 Y | 1.00 | infobox |
| Methotrexate | ECHA InfoCard | 100.000.376 | 1.00 | infobox |
| Methotrexate | Elimination half-life | 3–10 hours (lower doses), 8–15 hours (higher doses) | 1.00 | infobox |
| Methotrexate | Excretion | Urine (80–100%), feces (small amounts) | 1.00 | infobox |
| Methotrexate | Formula | C20H22N8O5 | 1.00 | infobox |
| Methotrexate | IUPHAR/BPS | 4815 | 1.00 | infobox |
| Methotrexate | KEGG | D00142 Y | 1.00 | infobox |
| Methotrexate | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Methotrexate | Legal status | CA: ℞-only | 1.00 | infobox |
| Methotrexate | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Methotrexate | Legal status | US: ℞-only | 1.00 | infobox |
| Methotrexate | Legal status | EU: Rx-only | 1.00 | infobox |
| Methotrexate | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Methotrexate | License data | US DailyMed: Methotrexate | 1.00 | infobox |
| Methotrexate | MedlinePlus | a682019 | 1.00 | infobox |
| Methotrexate | Metabolism | Hepatic and intracellular | 1.00 | infobox |
| Methotrexate | Molar mass | 454.447 g·mol−1 | 1.00 | infobox |
| Methotrexate | Other names | MTX, amethopterin | 1.00 | infobox |
| Methotrexate | PDB ligand | MTX (PDBe, RCSB PDB) | 1.00 | infobox |
| Methotrexate | Pregnancy category | AU: D | 1.00 | infobox |
| Methotrexate | Pronunciation | /ˌmɛθəˈtrɛkˌseɪt, ˌmiː-, -θoʊ-/ ⓘ | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.